The University of Southampton
University of Southampton Institutional Repository

Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome

Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome
Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome
Compared with medical therapy, percutaneous coronary intervention has been shown to reduce the rates of death and recurrent ischemia in patients presenting with acute coronary syndromes (ACS). In the current interventional era, both drug-eluting stents (DES) and bare-metal stents (BMS) have been widely used, despite the fact that the use of DES in the context of ACS was initially an “off-label” indication and that ACS has been associated with stent thrombosis (ST). In contrast to the wealth of data available for the use of DES in patients with ST-elevation myocardial infarction, data regarding the performance of DES in non–ST-elevation ACS is restricted to a handful of registries with conflicting data. The aim of this review was to summarize the safety and efficacy of DES in the entire spectrum of ACS.
1553-8389
385-390
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Delhaye, Cedric
d6bfe64b-8b52-4e6c-b505-497ef64195ff
Waksman, Ron
23d6bf65-0556-4930-8fad-224a559b34e0
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Delhaye, Cedric
d6bfe64b-8b52-4e6c-b505-497ef64195ff
Waksman, Ron
23d6bf65-0556-4930-8fad-224a559b34e0

Mahmoudi, Michael, Delhaye, Cedric and Waksman, Ron (2011) Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome. Cardiovascular Revascularization Medicine, 12 (6), 385-390. (doi:10.1016/j.carrev.2011.01.001).

Record type: Article

Abstract

Compared with medical therapy, percutaneous coronary intervention has been shown to reduce the rates of death and recurrent ischemia in patients presenting with acute coronary syndromes (ACS). In the current interventional era, both drug-eluting stents (DES) and bare-metal stents (BMS) have been widely used, despite the fact that the use of DES in the context of ACS was initially an “off-label” indication and that ACS has been associated with stent thrombosis (ST). In contrast to the wealth of data available for the use of DES in patients with ST-elevation myocardial infarction, data regarding the performance of DES in non–ST-elevation ACS is restricted to a handful of registries with conflicting data. The aim of this review was to summarize the safety and efficacy of DES in the entire spectrum of ACS.

This record has no associated files available for download.

More information

Accepted/In Press date: 7 January 2011
e-pub ahead of print date: 16 February 2011
Published date: November 2011
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 396126
URI: http://eprints.soton.ac.uk/id/eprint/396126
ISSN: 1553-8389
PURE UUID: 3d569749-272e-4170-94b4-dd6ba757c6d8
ORCID for Michael Mahmoudi: ORCID iD orcid.org/0000-0003-1293-8461

Catalogue record

Date deposited: 14 Jul 2016 15:53
Last modified: 15 Mar 2024 03:54

Export record

Altmetrics

Contributors

Author: Cedric Delhaye
Author: Ron Waksman

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×